{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T17:04:18Z","timestamp":1779728658790,"version":"3.53.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ando.2026.102524","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:17:28Z","timestamp":1774023448000},"page":"102524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic dyslipidemias"],"prefix":"10.1016","volume":"87","author":[{"given":"Bruno","family":"Verg\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ando.2026.102524_bib0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1050-1738(01)00071-8","article-title":"Intracellular assembly of VLDL: two major steps in separate cell compartments","volume":"10","author":"Olofsson","year":"2000","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.ando.2026.102524_bib0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2010.01.028","article-title":"Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes","volume":"211","author":"Verg\u00e8s","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ando.2026.102524_bib0180","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1194\/jlr.M017079","article-title":"Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI","volume":"53","author":"Ji","year":"2012","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.ando.2026.102524_bib0185","first-page":"e49121","article-title":"Familial hypercholesterolemia: a literature review of the pathophysiology and current and novel treatments","volume":"15","author":"Suryawanshi","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ando.2026.102524_bib0190","doi-asserted-by":"crossref","first-page":"bvaa122","DOI":"10.1210\/jendso\/bvaa122","article-title":"Management of familial hypercholesterolemia: current status and future perspectives","volume":"5","author":"Lui","year":"2021","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.ando.2026.102524_bib0195","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0000000000000609","article-title":"Monogenic, polygenic, and oligogenic familial hypercholesterolemia","volume":"30","author":"Tada","year":"2019","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.ando.2026.102524_bib0200","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOL.0000000000000397","article-title":"Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns","volume":"28","author":"Hopkins","year":"2017","journal-title":"Curr Opin Lipidol"},{"issue":"5520","key":"10.1016\/j.ando.2026.102524_bib0205","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein","volume":"292","author":"Garcia","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ando.2026.102524_bib0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.22215","article-title":"Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation","volume":"34","author":"Marduel","year":"2013","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.ando.2026.102524_bib0215","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ando.2026.102524_bib0220","doi-asserted-by":"crossref","first-page":"e016461","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ando.2026.102524_bib0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ando.2026.102524_bib0230","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs. polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"20","key":"10.1016\/j.ando.2026.102524_bib0235","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.ando.2026.102524_bib0240","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2020.08.004","article-title":"\u201cCholesterol-Years\u201d for ASCVD risk prediction and treatment","volume":"76","author":"Shapiro","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ando.2026.102524_bib0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MPG.0000000000000935","article-title":"Clinical features of lysosomal acid lipase deficiency","volume":"61","author":"Burton","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ando.2026.102524_bib0250","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fgene.2019.00336","article-title":"Diagnosis, phenotype, and molecular genetics of congenital analbuminemia","volume":"10","author":"Minchiotti","year":"2019","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.ando.2026.102524_bib0255","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jacl.2025.03.013","article-title":"Familial chylomicronemia syndrome: an expert clinical review from the National Lipid Association","volume":"19","author":"Javed","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ando.2026.102524_bib0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \u201cFCS score\u201d","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ando.2026.102524_bib0265","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2147\/DMSO.S206053","article-title":"Familial partial lipodystrophy (FPLD): recent insights","volume":"13","author":"Bagias","year":"2020","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"4","key":"10.1016\/j.ando.2026.102524_bib0270","first-page":"1085","article-title":"Heterozygous pathogenic PPARG variants in patients with severe hypertriglyceridemia","volume":"19","author":"Hang","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.ando.2026.102524_bib0275","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1210\/jc.2019-00849","article-title":"Diagnostic challenge in PLIN1-associated familial partial lipodystrophy","volume":"104","author":"J\u00e9ru","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ando.2026.102524_bib0280","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/ATVBAHA.124.320774","article-title":"Hypertriglyceridemia results from an impaired catabolism of triglyceride-rich lipoproteins in PLIN1-related lipodystrophy","volume":"44","author":"Verg\u00e8s","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.ando.2026.102524_bib0285","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jacl.2012.08.005","article-title":"Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism","volume":"6","author":"Sever","year":"2012","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.ando.2026.102524_bib0290","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1172\/JCI112704","article-title":"Familial apolipoprotein E deficiency","volume":"78","author":"Schaefer","year":"1986","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ando.2026.102524_bib0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MED.0000000000000316","article-title":"Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder","volume":"24","author":"Koopal","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"10.1016\/j.ando.2026.102524_bib0300","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.5551\/jat.RV17056","article-title":"Current diagnosis and management of abetalipoproteinemia","volume":"28","author":"Takahashi","year":"2021","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"10.1016\/j.ando.2026.102524_bib0305","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","article-title":"Hypobetalipoproteinemia and abetalipoproteinemia","volume":"25","author":"Welty","year":"2014","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"10.1016\/j.ando.2026.102524_bib0310","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ando.2026.102524_bib0315","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ando.2026.102524_bib0320","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.ando.2026.102524_bib0325","doi-asserted-by":"crossref","first-page":"e033654","DOI":"10.1161\/JAHA.123.033654","article-title":"Genetics and pathophysiological mechanisms of lipoprotein(a)-associated cardiovascular risk","volume":"13","author":"Volgman","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ando.2026.102524_bib0330","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J Clin Invest"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:26:04Z","timestamp":1779726364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426626000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0003426626000454"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2026.102524","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic dyslipidemias","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2026.102524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102524"}}